[HTML][HTML] Effect of CCL5 expression in the recruitment of immune cells in triple negative breast cancer
Triple negative breast cancer (TNBC) is the most aggressive form of breast cancer with
limited options of targeted therapy. Recent findings suggest that the clinical course of TNBC�…
limited options of targeted therapy. Recent findings suggest that the clinical course of TNBC�…
[PDF][PDF] Effect of CCL5expression in the recruitment of immune cells in triple negative breast cancer
JM Araujo, AC Gomez, A Aguilar, R Salgado…�- SCIENTIFIC�…, 2018 - academia.edu
Results Clinicopathological features according to CCL5 expression and TILs. In 72 TNBC
evaluated patients, the median age was 47.5 years (range: 24 to 78). There were not�…
evaluated patients, the median age was 47.5 years (range: 24 to 78). There were not�…
[HTML][HTML] Effect of CCL5 expression in the recruitment of immune cells in triple negative breast cancer
JM Araujo, AC Gomez, A Aguilar, R Salgado…�- Scientific�…, 2018 - ncbi.nlm.nih.gov
Triple negative breast cancer (TNBC) is the most aggressive form of breast cancer with
limited options of targeted therapy. Recent findings suggest that the clinical course of TNBC�…
limited options of targeted therapy. Recent findings suggest that the clinical course of TNBC�…
Effect of CCL5 expression in the recruitment of immune cells in triple negative breast cancer.
JM Araujo, AC Gomez, A Aguilar, R Salgado…�- Scientific�…, 2018 - europepmc.org
Triple negative breast cancer (TNBC) is the most aggressive form of breast cancer with
limited options of targeted therapy. Recent findings suggest that the clinical course of TNBC�…
limited options of targeted therapy. Recent findings suggest that the clinical course of TNBC�…
Effect of CCL5 expression in the recruitment of immune cells in triple negative breast cancer
JM Araujo, AC Gomez, A Aguilar…�- Scientific�…, 2018 - pubmed.ncbi.nlm.nih.gov
Triple negative breast cancer (TNBC) is the most aggressive form of breast cancer with
limited options of targeted therapy. Recent findings suggest that the clinical course of TNBC�…
limited options of targeted therapy. Recent findings suggest that the clinical course of TNBC�…
Effect of CCL5 expression in the recruitment of immune cells in triple negative breast cancer
JM Araujo, AC Gomez, A Aguilar, R Salgado…�- Scientific�…, 2018 - ui.adsabs.harvard.edu
Triple negative breast cancer (TNBC) is the most aggressive form of breast cancer with
limited options of targeted therapy. Recent findings suggest that the clinical course of TNBC�…
limited options of targeted therapy. Recent findings suggest that the clinical course of TNBC�…
Effect of CCL5 expression in the recruitment of immune cells in triple negative breast cancer
JM Araujo, AC Gomez, A Aguilar, R Salgado…�- Scientific Reports, 2018 - cir.nii.ac.jp
抄録< jats: title> Abstract</jats: title>< jats: p> Triple negative breast cancer (TNBC) is the
most aggressive form of breast cancer with limited options of targeted therapy. Recent�…
most aggressive form of breast cancer with limited options of targeted therapy. Recent�…
[PDF][PDF] Effect of CCL5expression in the recruitment of immune cells in triple negative breast cancer
JM Araujo, AC Gomez, A Aguilar, R Salgado…�- SCIENTIFIC�…, 2018 - academia.edu
Results Clinicopathological features according to CCL5 expression and TILs. In 72 TNBC
evaluated patients, the median age was 47.5 years (range: 24 to 78). There were not�…
evaluated patients, the median age was 47.5 years (range: 24 to 78). There were not�…